Event Preview - Kinase 2016: Next Generation Inhibitors
2 Feb 2016
Perturbation of cell signalling through inhibition of kinase enzymes has delivered nearly 30 approved medicines to date. The seventh SCI/RSC symposium on kinase inhibitor design will feature diverse medicinal chemistry case studies, first disclosures, new technology applications, and lessons from history to provide insight into the future direction of the field. A packed scientific agenda of top international scientists from the field has been assembled, including:
- Mark Bunnage, Pfizer - Kinase drug discovery: past, present, and future
- Celine Cano, NICR - Development of potent inhibitors of the DNA-dependent protein kinase (Roger Griffin Memorial Lecture)
- Phil Harris, GSK - Identification of highly potent and mono-selective RIP1 kinase inhibitors targeting a unique allosteric pocket
- Duncan Shaw, Novartis - PDGFR inhibitors suitable for inhalation as a treatment for lung remodeling in PAH
- Christel Menet, Galapagos - Filgotinib: a selective JAK1 inhibitor
- Stefan Knapp, Johann Wolfgang Goethe-University - Design strategies for the development of selective kinase inhibitors
In addition to a packed agenda, there will be a scientific poster exhibition preceded by short oral
Kinase 2016: Next Generation Inhibitors will take place on Monday 16 - Tuesday 17 May 2016 at BioCity, Nottingham organised by SCI’s Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector; in partnership with Sygnature Discovery.
Accommodation and Conference Dinner
Enjoy 2 nights bed and breakfast at Jurys Inn, Nottingham, for the special rate of £90.00. To take advantage of this rate, please select accommodation when booking.
As part of your conference registration, the organising committee invite you to join them for a drinks reception on Sunday 15 May at Jurys Inn, Nottingham and conference buffet dinner on Monday 16 May at The Riverbank Bar and Kitchen (transportation will be provided from the conference venue).
This promises to be an unmissable event for any drug discovery scientist wishing to further their knowledge of kinase research.
Make sure to book your place by Friday 1 April to take advantage of the early bird delegate rates. Poster submissions are being accepted until Friday 18 March.